Myelodysplastic-Myeloproliferative Diseases - 25 Studies Found
Completed |
: Bone Marrow Transplant Plus Cyclophosphamide and Total-Body Irradiation in Treating Patients With Hematologic Cancer :
|
Completed |
: Efficacy Study of Revlimid® and Low Dose Continuously Administered Melphalan to Treat Higher Risk Myelodysplastic Syndromes :
: 2003-12-19 : Drug: DTGM Starting dose: 2 mcg/kg by vein three times a week (M,W,F) for two consecutive weeks. |
Completed |
: S9910, Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer :
|
Terminated |
: Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Cancer :
: |